Demonstrating the Beneficial Effect of Low Protein Diet in Primary Sclerosing Cholangitis through a Randomized Clinical Trial and Multi-omics Data Analysis
Yin, X.; Sasson, G.; Sun, Z.; Ke, S.; Babazadeh, D.; Mahmood, S. D.; Andrews, M.; Hurwitz, S.; Chikowore, T.; Paul, M.; Javier, N.; Dave, M.; Austin, A.; Gray, L.; Steinberg, F.; Souza, E.; Bowlus, C.; Liu, Y.-Y.; Korzenik, J.
Show abstract
Primary sclerosing cholangitis (PSC), a progressive cholestatic hepatobiliary disease characterized by inflammation and fibrosis of the bile ducts, has a pathophysiology that is not understood. No effective therapies exist. The only treatment option for PSC is liver transplant. We undertook a pilot randomized trial of diet to investigate the pathophysiology of the disease, the role of diet and to advance potential therapy. We enrolled 20 patients with PSC and randomly assigned them to a Low Protein/low sulfur Diet (LPD, n=10) or the Specific Carbohydrate Diet (SCD, n=10) for 8 weeks. Results showed that low protein intake benefits PSC patients, whereas higher protein levels exacerbate the condition. We further identified gut bacterial markers useful for distinguishing LPD responders (mostly PSC with concomitant ulcerative colitis) from non-responders. Additionally, by integrating multi-omics data, we propose that this diet modifies the intestinal sulfur cycle reducing hydrogen sulfide (H2S) production. Our findings provide an understanding of the beneficial effect of LPD as well as insights into a possible key driver of inflammation in PSC.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Enhancing Recovery from Gut Microbiome Dysbiosis and Alleviating DSS-Induced Colitis in Mice with a Consortium of Rare Short-Chain Fatty Acid-Producing Bacteria 96%
- Gut Microbiota and Derived Metabolites Mediate Obstructive Sleep Apnea Induced Atherosclerosis 95%
- Comparative Analysis of the Duodenojejunal Microbiome with the oral and fecal microbiome unveils its role in Human Severe Obesity 95%
Similar papers in this journal
- Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation 96%
- Gut microbiome, diet and symptom interactions in irritable bowel syndrome 95%
- Microbiota responses to different prebiotics are conserved within individuals and associated with habitual fiber intake 95%
Similar papers in this journal
- Microbiota from young mice counteracts susceptibility to age-related gout through modulating butyric acid levels in aged mice 95%
- A hepatocyte-specific transcriptional program driven by Rela and Stat3 exacerbates experimental colitis in mice by modulating bile synthesis 95%
- Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice 94%
Similar papers in this journal
- Dietary Exposure to Antibiotic Residues Facilitates Metabolic Disorder by Altering the Gut Microbiota and Bile Acid Composition 95%
- Elemental diet enriched in amino acids alters gut microbial community and prevents colonic mucus degradation in mice with colitis 95%
- Steamed broccoli sprouts alleviate DSS-induced inflammation and retain gut microbial biogeography in mice. 95%